Literature DB >> 31133456

The C3a/C3aR axis mediates anti-inflammatory activity and protects against uropathogenic E coli-induced kidney injury in mice.

Kun-Yi Wu1, Ting Zhang1, Guo-Xiu Zhao1, Ning Ma1, Shu-Juan Zhao1, Na Wang1, Jia-Xing Wang1, Zong-Fang Li2, Wuding Zhou3, Ke Li4.   

Abstract

Both the C3a/C3aR and C5a/C5aR1 axes are regarded as important pathways for inducing and regulating inflammatory responses. It is well documented that the C5a/C5aR1 axis is a potent inflammatory mediator in the pathogenesis of many clinic disorders. However, our understanding of the role of the C3a/C3aR axis in renal disorders remains limited. Contrary to the C5a/C5aR axis, we now show that the C3a/C3aR axis has a protective role in uropathogenic Escherichia coli (UPEC)-induced renal injury. C3aR-/- mice were found to develop severe renal pathology compared to wild type mice, a pathology characterized by intense tissue damage and an increased bacterial load within the kidney. This was associated with an overwhelming production of pro-inflammatory mediators and increased neutrophil infiltration in the kidney. Bone marrow chimera experiments found that tissue damage and bacterial load were significantly reduced in C3aR-/- mice that received bone marrow from wild type mice, compared with that in mice re-populated with bone marrow from C3aR-/- mice. This supports a critical role for C3aR on myeloid cells in the pathological process. Pharmacological treatment of mice with a C3aR agonist reduced both the extent of tissue injury and bacterial load. Mechanistic analyses indicated that the C3a/C3aR axis downregulates the lipopolysaccharide-induced pro-inflammatory responses in macrophages and facilitates the phagocytosis of UPEC by phagocytes. Thus, our findings clearly demonstrate a protective role of the C3a/C3aR axis in UPEC-induced renal injury, conferred by the suppression of pro-inflammatory responses and enhanced phagocytosis by macrophages.
Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C3a/C3aR axis; inflammatory response; kidney infection; phagocytosis

Mesh:

Substances:

Year:  2019        PMID: 31133456     DOI: 10.1016/j.kint.2019.03.005

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  The complement C3a-C3aR and C5a-C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF-κB signaling.

Authors:  Shasha Luo; Huiyan Xu; Xuechun Gong; Jinyan Shen; Xuan Chen; Zhifeng Wu
Journal:  Exp Ther Med       Date:  2022-06-07       Impact factor: 2.751

Review 2.  C3aR plays both sides in regulating resistance to bacterial infections.

Authors:  Jesse A Corcoran; Brooke A Napier
Journal:  PLoS Pathog       Date:  2022-08-04       Impact factor: 7.464

Review 3.  The role of complement in nonalcoholic fatty liver disease.

Authors:  Zhenya Guo; Xiude Fan; Jianni Yao; Stephen Tomlinson; Guandou Yuan; Songqing He
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

4.  Genome-scale CRISPR screening reveals that C3aR signaling is critical for rapid capture of fungi by macrophages.

Authors:  Allison Cohen; Edwin E Jeng; Mark Voorhies; Jane Symington; Nebat Ali; Rosa A Rodriguez; Michael C Bassik; Anita Sil
Journal:  PLoS Pathog       Date:  2022-09-29       Impact factor: 7.464

5.  The C5a/C5aR2 axis promotes renal inflammation and tissue damage.

Authors:  Ting Zhang; Kun-Yi Wu; Ning Ma; Ling-Lin Wei; Malgorzata Garstka; Wuding Zhou; Ke Li
Journal:  JCI Insight       Date:  2020-04-09

Review 6.  The Complement C3a and C3a Receptor Pathway in Kidney Diseases.

Authors:  Shuang Gao; Zhao Cui; Ming-Hui Zhao
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.